Sodium cyanate induced polyneuropathy in patients with sickle-cell disease.
D000293:Adolescent; D000328:Adult; D000755:Anemia, Sickle Cell / Q000150:complications / Q000188:drug therapy*; D001706:Biopsy; D001835:Body Weight; D002648:Child; D003485:Cyanates / Q000008:administration & dosage / Q000009:adverse effects* / Q000302:isolation & purification / Q000627:therapeutic use; D004576:Electromyography; D004912:Erythrocytes / Q000187:drug effects; D005260:Female; D006801:Humans; D008875:Middle Aged; D009413:Nerve Fibers, Myelinated; D009431:Neural Conduction; D009443:Neuritis / Q000473:pathology; D011115:Polyneuropathies / Q000139:chemically induced*; D012018:Reflex; D013497:Sural Nerve / Q000473:pathology; D013697:Thermosensing; D014110:Touch
D003485:Cyanates